| Product Code: ETC320727 | Publication Date: Aug 2022 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Singapore corticosteroid market, the import trend experienced a slight decline from 2023 to 2024, with a growth rate of -1.31%. However, the compound annual growth rate (CAGR) for imports from 2020 to 2024 stood at a notable 31.32%. This shift in import momentum could be attributed to evolving demand dynamics or changes in market stability.

The Singapore corticosteroid market forms a crucial part of the pharmaceutical industry, catering to various medical conditions. Corticosteroids are synthetic drugs that mimic the body`s natural hormones and are used to treat a wide range of inflammatory and immune-related disorders. As Singapore healthcare system continues to advance, the demand for corticosteroid medications for conditions such as asthma, arthritis, and dermatological issues has been on the rise. The market`s growth is driven by both medical advancements and the country`s aging population, which leads to an increased prevalence of conditions that require corticosteroid treatments.
The Singapore corticosteroid market is expanding due to a range of factors. Firstly, the prevalence of skin disorders, allergies, and inflammatory conditions has increased the demand for corticosteroid-based pharmaceuticals. These drugs are effective in managing various medical conditions, including dermatological issues and respiratory ailments. Secondly, the aging population in Singapore has led to a higher incidence of chronic diseases, further driving the demand for corticosteroid medications. Lastly, advancements in drug formulations and delivery methods have made corticosteroids more accessible and convenient, contributing to market growth.
The corticosteroid market in Singapore faces challenges related to regulatory compliance and patent expirations. Stringent regulations govern the pharmaceutical industry, requiring companies to invest heavily in research and development, clinical trials, and compliance measures. Additionally, as patents for certain corticosteroid drugs expire, generic competition intensifies, impacting pricing and market share. Navigating this landscape while ensuring product quality and compliance is a complex task for industry players.
The Singapore corticosteroid market witnessed fluctuations during the COVID-19 pandemic. Corticosteroids are pharmaceutical products used for a wide range of medical conditions, including inflammatory and autoimmune diseases. The pandemic led to increased demand for corticosteroids in the treatment of severe COVID-19 cases, including the use of dexamethasone. This surge in demand put pressure on the supply chain, leading to temporary shortages and price fluctuations. However, as the healthcare system adapted to the situation and manufacturers ramped up production, the market stabilized. Corticosteroids remained essential for managing various medical conditions, ensuring their continued demand. The market is expected to remain steady with a focus on pharmaceutical supply chain resilience.
In the Singapore Corticosteroid market, pharmaceutical companies like GlaxoSmithKline (GSK), AstraZeneca, and Pfizer are prominent players. They produce corticosteroid medications used for various medical conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Corticosteroid Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Corticosteroid Market Revenues & Volume, 2022 & 2032F |
3.3 Singapore Corticosteroid Market - Industry Life Cycle |
3.4 Singapore Corticosteroid Market - Porter's Five Forces |
3.5 Singapore Corticosteroid Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Singapore Corticosteroid Market Revenues & Volume Share, By Administration, 2022 & 2032F |
3.7 Singapore Corticosteroid Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Singapore Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases that require corticosteroid treatment |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various medical conditions |
4.2.3 Technological advancements leading to the development of innovative corticosteroid products |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for corticosteroid medications |
4.3.2 Potential side effects and adverse reactions associated with long-term corticosteroid use |
4.3.3 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) and biologics |
5 Singapore Corticosteroid Market Trends |
6 Singapore Corticosteroid Market, By Types |
6.1 Singapore Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Singapore Corticosteroid Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Singapore Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2022-2032F |
6.1.4 Singapore Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2022-2032F |
6.2 Singapore Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Singapore Corticosteroid Market Revenues & Volume, By Topical Steroids, 2022-2032F |
6.2.3 Singapore Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2022-2032F |
6.2.4 Singapore Corticosteroid Market Revenues & Volume, By Oral Forms, 2022-2032F |
6.2.5 Singapore Corticosteroid Market Revenues & Volume, By Systemic Forms, 2022-2032F |
6.2.6 Singapore Corticosteroid Market Revenues & Volume, By Others, 2022-2032F |
6.3 Singapore Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Singapore Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2022-2032F |
6.3.3 Singapore Corticosteroid Market Revenues & Volume, By Skin Allergies, 2022-2032F |
6.3.4 Singapore Corticosteroid Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.3.5 Singapore Corticosteroid Market Revenues & Volume, By Gastroenterology, 2022-2032F |
6.3.6 Singapore Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2022-2032F |
6.3.7 Singapore Corticosteroid Market Revenues & Volume, By Others, 2022-2032F |
7 Singapore Corticosteroid Market Import-Export Trade Statistics |
7.1 Singapore Corticosteroid Market Export to Major Countries |
7.2 Singapore Corticosteroid Market Imports from Major Countries |
8 Singapore Corticosteroid Market Key Performance Indicators |
8.1 Patient adherence rate to corticosteroid treatment regimens |
8.2 Number of new product launches or innovations in the corticosteroid market |
8.3 Prescription rates of corticosteroids by healthcare providers |
8.4 Patient satisfaction and feedback on corticosteroid therapies |
8.5 Research and development investment in corticosteroid medications |
9 Singapore Corticosteroid Market - Opportunity Assessment |
9.1 Singapore Corticosteroid Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Singapore Corticosteroid Market Opportunity Assessment, By Administration, 2022 & 2032F |
9.3 Singapore Corticosteroid Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Singapore Corticosteroid Market - Competitive Landscape |
10.1 Singapore Corticosteroid Market Revenue Share, By Companies, 2025 |
10.2 Singapore Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here